MANUFACTURING SUPPORT SERVICES AGREEMENT dated as of June 30, 2005 by and among ABBOTT JAPAN CO., LTD. (“Abbott Japan”); ABBOTT LABORATORIES (“Abbott Laboratories”); INVERNESS MEDICAL INNOVATIONS, INC. (“Parent”); INVERNESS MEDICAL SWITZERLAND GmbH...Manufacturing Support Services Agreement • August 15th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Illinois
THIS MANUFACTURING SUPPORT SERVICES AGREEMENT (this “Agreement”) is made this 30th day of June 2005 (the “Effective Date”), by and among Abbott Japan Co., Ltd., a Japanese corporation (“Abbott Japan”); and Abbott Laboratories, an Illinois corporation (“Abbott Laboratories” and together with Abbott Japan, “Seller”), on the one hand, and Inverness Medical Innovations, Inc., a Delaware corporation (“Parent”); Inverness Medical Switzerland GmbH, an entity organized under the laws of Switzerland (“Inverness Switzerland”) and Inverness Medical Japan, Ltd., an entity organized under the laws of Japan (“Inverness Japan” and, together with Parent and Inverness Switzerland, “Buyer”), on the other hand.
INCENTIVE STOCK OPTION AGREEMENT UNDER THE INVERNESS MEDICAL INNOVATIONS, INC. 2001 STOCK OPTION AND INCENTIVE PLANIncentive Stock Option Agreement • August 15th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR SENIOR EXECUTIVES UNDER THE INVERNESS MEDICAL INNOVATIONS, INC. 2001 STOCK OPTION AND INCENTIVE PLANNon-Qualified Stock Option Agreement • August 15th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
REAGENT SUPPLY AGREEMENT dated as of June 30, 2005 by and among ABBOTT LABORATORIES (“Seller”); and INVERNESS MEDICAL INNOVATIONS, INC. (“Parent”); and INVERNESS MEDICAL JAPAN, LTD. (“Inverness Japan”)Reagent Supply Agreement • August 15th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
THIS REAGENT SUPPLY AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2005, by and among Inverness Medical Innovations, Inc. a Delaware corporation (“Parent”), and Inverness Medical Japan, Ltd., an entity organized under the laws of Japan (“Inverness Japan” and, together with Parent, “Buyer”), on the one hand, and Abbott Laboratories, an Illinois corporation (“Seller”), on the other hand.
LEASE BETWEEN WE 10 SOUTHGATE LLC (“LANDLORD”) AND BINAX, INC. (“TENANT”) dated as of August 26, 2004Lease Agreement • August 15th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Maine
NON-QUALIFIED STOCK OPTION AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER THE INVERNESS MEDICAL INNOVATIONS, INC. 2001 STOCK OPTION AND INCENTIVE PLANNon-Qualified Stock Option Agreement • August 15th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances
Pursuant to the Inverness Medical Innovations, Inc. 2001 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Inverness Medical Innovations, Inc. (the “Company”) hereby grants to the Optionee named above, who is a member of the Board of Directors of the Company (a “Director”) but is not an employee of the Company, an option (the “Stock Option”) to purchase, on or prior to the Expiration Date specified above, all or part of the number of Option Shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
